Pharma Mar SA
MAD:PHM
Wall Street
Price Targets
PHM Price Targets Summary
Pharma Mar SA
According to Wall Street analysts, the average 1-year price target for
PHM
is 95.88 EUR
with a low forecast of 30.3 EUR and a high forecast of 123.9 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PHM's stock price target?
Price Target
95.88
EUR
According to Wall Street analysts, the average 1-year price target for
PHM
is 95.88 EUR
with a low forecast of 30.3 EUR and a high forecast of 123.9 EUR.
What is Pharma Mar SA's Revenue forecast?
Projected CAGR
26%
For the last 8 years the
compound annual growth rate for
Pharma Mar SA's revenue is
0%.
The projected
CAGR
for the next 3 years is
26%.
What is Pharma Mar SA's Operating Income forecast?
Projected CAGR
190%
The
compound annual growth rate
of Pharma Mar SA's operating income for the next 3 years is
190%.
What is Pharma Mar SA's Net Income forecast?
Projected CAGR
53%
The
compound annual growth rate
of Pharma Mar SA's net income for the next 3 years is
53%.
You don't have any saved screeners yet
